{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:51:20Z","timestamp":1789026680164,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","award":["ERC-2022-PoC1-101069308"],"award-info":[{"award-number":["ERC-2022-PoC1-101069308"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-StG 637830"],"award-info":[{"award-number":["ERC-StG 637830"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejpb.2023.11.007","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T11:44:16Z","timestamp":1699703056000},"page":"218-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying"],"prefix":"10.1016","volume":"193","author":[{"given":"Christoph M.","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"De\u00dfloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"J\u00fcrgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.11.007_b0005","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2023.11.007_b0010","doi-asserted-by":"crossref","first-page":"e2106580","DOI":"10.1002\/smll.202106580","article-title":"Microfluidic Nanoparticles for Drug Delivery","volume":"18","author":"Liu","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2023.11.007_b0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2023.11.007_b0020","unstructured":"B. Wire, Alnylam Announces Approval of GIVLAARI (givosiran) by the U.S. Food and Drug Administration (FDA, (2019) 1-6."},{"key":"10.1016\/j.ejpb.2023.11.007_b0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.11.007_b0030","article-title":"Challenges of storage and stability of mRNA-based COVID-19 vaccines","volume":"9","author":"Uddin","year":"2021","journal-title":"Vaccines (basel)"},{"key":"10.1016\/j.ejpb.2023.11.007_b0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.vaccine.2020.12.017","article-title":"Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy","volume":"39","author":"Holm","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2023.11.007_b0040","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.11.007_b0045","doi-asserted-by":"crossref","unstructured":"Z. Kis, Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain, Pharmaceutics, 14 (2022).","DOI":"10.3390\/pharmaceutics14020430"},{"key":"10.1016\/j.ejpb.2023.11.007_b0050","unstructured":"EMA, Onpattro - Product information, (2022) 1-31."},{"key":"10.1016\/j.ejpb.2023.11.007_b0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IJN.S123062","article-title":"Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Ball","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2023.11.007_b0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2015.10.024","article-title":"siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo","volume":"220","author":"Suzuki","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.11.007_b0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1248\/bpb.b18-00208","article-title":"Development of an alcohol dilution-lyophilization method for preparing lipid nanoparticles containing encapsulated siRNA","volume":"41","author":"Shirane","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2023.11.007_b0070","first-page":"11","article-title":"Delivery strategies for mRNA vaccines","volume":"36","author":"Ramachandran","year":"2022","journal-title":"Pharmaceut. Med."},{"key":"10.1016\/j.ejpb.2023.11.007_b0075","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.foodres.2018.10.056","article-title":"Influence of spray drying on the stability of food-grade solid lipid nanoparticles","volume":"119","author":"Salminen","year":"2019","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ejpb.2023.11.007_b0080","article-title":"Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles","volume":"1\u201315","author":"Keil","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejpb.2023.11.007_b0085","unstructured":"M.K.H.a.Y.H. Roos, Water Plasticization and Crystallization of Lactose in Spray-dried Lactose\/Protein Mixtures, J. Food Sci., 69 (2008) 23-29."},{"key":"10.1016\/j.ejpb.2023.11.007_b0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/js960257o","article-title":"How does residual water affect the solid-state degradation of drugs in the amorphous state?","volume":"85","author":"Evgenyi","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.11.007_b0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11095-019-2663-y","article-title":"Identification of Factors of importance for spray drying of small interfering RNA-loaded lipidoid-polymer hybrid nanoparticles for inhalation","volume":"36","author":"Dormenval","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.11.007_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2011.08.011","article-title":"Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA","volume":"157","author":"Jensen","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.11.007_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","author":"Zimmermann","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.11.007_b0110","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/bm401849d","article-title":"Influence of oligospermines architecture on their suitability for siRNA delivery","volume":"15","author":"Elsayed","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2023.11.007_b0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/mp100101s","article-title":"Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity","volume":"7","author":"Merkel","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2023.11.007_b0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acs.biomac.5b01189","article-title":"Folate receptor targeted delivery of siRNA and paclitaxel to ovarian cancer cells via folate conjugated triblock copolymer to overcome TLR4 driven chemotherapy resistance","volume":"17","author":"Jones","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2023.11.007_b0125","unstructured":"M. Ciufolini, M.L. Ferguson, Sulfur-containing lipids, in: T.U.o.B. Columbia (Ed.), Canada, 2021."},{"key":"10.1016\/j.ejpb.2023.11.007_b0130","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid Nanoparticle technology for clinical translation of siRNA therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejpb.2023.11.007_b0135","first-page":"1","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2023.11.007_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100161","article-title":"Lab-scale siRNA and mRNA LNP manufacturing by various microfluidic mixing techniques \u2013 an evaluation of particle properties and efficiency","volume":"12","author":"J\u00fcrgens","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.ejpb.2023.11.007_b0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-0363-4_6","article-title":"Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications","volume":"1141","author":"Walsh","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejpb.2023.11.007_b0150","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.biomaterials.2010.11.081","article-title":"Polymer-related off-target effects in non-viral siRNA delivery","volume":"32","author":"Merkel","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2023.11.007_b0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.1987.190","article-title":"A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity","volume":"56","author":"Twentyman","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejpb.2023.11.007_b0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/02786828508959051","article-title":"On the calculation of aerodynamic diameters of fibers","volume":"4","author":"Gonda","year":"2011","journal-title":"Aerosol Sci. Tech."},{"key":"10.1016\/j.ejpb.2023.11.007_b0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thx.51.10.977","article-title":"Optimal particle size for b2 agonist and anticholinergic aerosols in patients with severe airflow obstruction","volume":"51","author":"Pieter Zanen","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.ejpb.2023.11.007_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00113-L","article-title":"Mechanisms of macromolecule absorption by the lungs","volume":"19","author":"Patton","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.11.007_b0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2023.11.007_b0180","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1021\/acsami.1c14975","article-title":"Hybrid lipid\/polymer nanoparticles to tackle the cystic fibrosis mucus barrier in siRNA delivery to the lungs: does PEGylation make the Difference?","volume":"14","author":"Conte","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2023.11.007_b0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jconrel.2022.03.051","article-title":"Inhibition of SARS-CoV-2 replication in the lung with siRNA\/VIPER polyplexes","volume":"345","author":"Baldassi","year":"2022","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:55:16Z","timestamp":1760547316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":37,"alternative-id":["S0939641123002965"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.11.007","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}